Impact BioMedical (IBO) Q4 2024 Annual Earnings

IBO·Reported March 28, 2025·Before market open

Diluted EPS came in at $-0.42.

Diluted EPS

$-0.42

SEC Filings

Earnings release8-K not filed yet

Annual report10-K · 0001641172-25-001199

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q4 2024 Earnings FAQ

Common questions about Impact BioMedical's Q4 2024 earnings report.

Impact BioMedical (IBO) reported Q4 2024 earnings on March 28, 2025 before market open.

Impact BioMedical reported diluted EPS of $-0.42 for Q4 2024.

You can read the 10-K periodic report (0001641172-25-001199) directly on SEC EDGAR. The filing index links above go to sec.gov.